1. ORs estimates for ER breast cancer subtypes in postmenopausal women ccording to tertiles of sex steroid hormone and SHBG levels.
ORs estimates for ER breast cancer subtypes in postmenopausal women ccording to tertiles of sex steroid hormone and SHBG levels. Cases and controls matched for study center, batch, age at blood donation, time of blood collection, and fasting status. *, test for heterogeneity between ER-positive and ER-negative breast cancer was assessed using a log likelihood ratio test with and without an interaction term for breast cancer subtype outcome. **, Log2 continuous increase in circulating hormone level.
Rebecca E. James et al. Cancer Prev Res 2011;4:
©2011 by American Association for Cancer Research